A.V. Trask
- Physical and Theoretical Chemistry top 0.05%
- Crystallography and molecular interactions 11
- Inorganic Chemistry top 2%
- Crystal structures of chemical compounds 4
- Materials Chemistry top 2%
- Crystallization and Solubility Studies 9
- X-ray Diffraction in Crystallography 3
- Pharmaceutical Science top 1%
- Spectroscopy top 2%
-
- Phenothiazines and Benzothiazines Synthesis and Activities 2
- Chemical Synthesis and Analysis 1
-
- Innovative Microfluidic and Catalytic Techniques Innovation 1
-
- Biomedical Ethics and Regulation 1
- Co-authors
- William JonesW. D. Samuel MotherwellW.D.S. MotherwellW. JonesTomislav FriščićJacco van de StreekDelia A. HaynesJon Bordner
- Partner nations
- United KingdomUnited StatesSingapore
In The Last Decade
A.V. Trask
16 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Physical and Theoretical Chemistry 2.7k
- Inorganic Chemistry 836
- Materials Chemistry 2.4k
- Pharmaceutical Science 258
- Spectroscopy 488
Countries citing papers authored by A.V. Trask
This map shows the geographic impact of A.V. Trask's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.V. Trask with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.V. Trask more than expected).
Fields of papers citing papers by A.V. Trask
This network shows the impact of papers produced by A.V. Trask. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.V. Trask. The network helps show where A.V. Trask may publish in the future.
Co-authorship network
The 15 scholars most cited alongside A.V. Trask, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | "Obvious to try": a proper patentability standard in the pharmaceutical arts? | 2008 | 2 |
| 2 | 2008 | 97 | |
| 3 | 2007 | 311 | |
| 4 | Physical stability enhancement of theophylline via cocrystallizationbreakdown → | 2006 | 486 |
| 5 | 2006 | 340 | |
| 6 | 2006 | 169 | |
| 7 | 2006 | 342 | |
| 8 | 2006 | 66 | |
| 9 | 2005 | 170 | |
| 10 | 2005 | 129 | |
| 11 | 2005 | 73 | |
| 12 | 2005 | 0 | |
| 13 | 2005 | 180 | |
| 14 | Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydrationbreakdown → | 2005 | 583 |
| 15 | 2004 | 346 | |
| 16 | 2004 | 3 | |
| 17 | 2004 | 7 |
About A.V. Trask
A.V. Trask is a scholar working on Physical and Theoretical Chemistry, Inorganic Chemistry, Materials Chemistry, Pharmaceutical Science and Management of Technology and Innovation, having authored 17 papers that have together received 3.3k indexed citations. Recurring topics across this work include Crystallography and molecular interactions (11 papers), Crystallization and Solubility Studies (9 papers), Crystal structures of chemical compounds (4 papers), X-ray Diffraction in Crystallography (3 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (1 paper), Chemical Synthesis and Analysis (1 paper) and Biomedical Ethics and Regulation (1 paper). The work is most often cited by research in Physical and Theoretical Chemistry (2.7k citations), Inorganic Chemistry (836 citations), Materials Chemistry (2.4k citations), Pharmaceutical Science (258 citations) and Spectroscopy (488 citations). A.V. Trask has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include William Jones, W. D. Samuel Motherwell, W.D.S. Motherwell, W. Jones, Tomislav Friščić, Jacco van de Streek, Delia A. Haynes, Jon Bordner, Yuriy A. Abramov and A Medek. Their work appears in journals such as Chemical Communications, Crystal Growth & Design, CrystEngComm, Journal of the American Chemical Society and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.